Catholic University of Korea, Seoul
Novel oncogene HCCR analyzed
Published in Oncology Business Week, September 4th, 2005
According to recent research from South Korea, "Identification of robust diagnostic and therapeutic target molecules for human malignancy is still an important issue. If we identify novel proteins which play a stem-line role for cellular transformation or aggravation of malignancy, it could give us a clue to diagnose a tumor in an earlier stage and to develop more reliable therapeutic tools."
"For this purpose, we have screened abnormally expressed genes in various human cancers by differential display RT-PCR. One of the overexpressed genes was HCCR. HCCR was not only...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Amgen
U.S. FDA grants panitumumab fast-track status for metastatic colorectal cancer - Amgen Inc.
Palifermin compound receives positive regulatory opinion for approval in Europe - Genitope Corp.
Cancer-focused immunotherapy company reports Q2 net loss of $8.2 million - GlobeImmune, Inc.
Immunotherapy company names Francis V. Chisari, MD, to scientific advisory board - Infrared Sciences Corp.
Maker of breast cancer detection system receives $2.1 million additional funding - Northwest Biotherapeutics, Inc.
Biotechnology company announces appointment of medical director - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
